Cargando…

The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice

BACKGROUND AND AIMS: Mirtazapine is an atypical antidepressant with antagonist activity for serotonin and histamine receptors. Clinical and experimental evidence suggests that, in addition to treating depression, mirtazapine also alters liver innate immunity and suppresses immune-driven hepatic macr...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Rachelle Paige, Almishri, Wagdi, Jenne, Craig Neal, Swain, Mark Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673391/
https://www.ncbi.nlm.nih.gov/pubmed/33250892
http://dx.doi.org/10.3389/fimmu.2020.578654
_version_ 1783611309810515968
author Davis, Rachelle Paige
Almishri, Wagdi
Jenne, Craig Neal
Swain, Mark Gordon
author_facet Davis, Rachelle Paige
Almishri, Wagdi
Jenne, Craig Neal
Swain, Mark Gordon
author_sort Davis, Rachelle Paige
collection PubMed
description BACKGROUND AND AIMS: Mirtazapine is an atypical antidepressant with antagonist activity for serotonin and histamine receptors. Clinical and experimental evidence suggests that, in addition to treating depression, mirtazapine also alters liver innate immunity and suppresses immune-driven hepatic macrophage activation. Liver macrophages, Kupffer cells, represent the largest collection of fixed macrophages in the body and are critical in regulating hepatic immunity. In addition to their capacity to regulate inflammation, Kupffer cells are key sentinels for clearing blood-borne pathogens, preventing their dissemination within the body. This process involves pathogen capture, phagocytosis, and activation-induced killing via reactive oxygen species (ROS) production. Therefore, we speculated that mirtazapine might adversely alter Kupffer cell pathogen-associated activation and killing. METHODS: Mice were treated with mirtazapine and time-dependent changes in Kupffer cells were characterized using intravital microscopy. Macrophage and neutrophil responses, bacterial dissemination, and liver damage were assessed following i.v. infection with a pathogenic strain of S. aureus. RESULTS: Mirtazapine rapidly (within 1.5 h) activates Kupffer cells, indicated by a loss of elongated shape with cellular rounding. However, this shape change did not result in impaired pathogen capture function, and, in fact, generated enhanced ROS production in response to S. aureus-induced sepsis. Neutrophil dynamics were altered with reduced cellular recruitment to the liver following infection. Bacterial dissemination post-intravenous administration was not altered by mirtazapine treatment; however, hepatic abscess formation was significantly reduced. CONCLUSIONS: Mirtazapine rapidly activates Kupffer cells, associated with preserved bacterial capture functions and enhanced ROS generation capacity. Moreover, these changes in Kupffer cells were linked to a beneficial reduction in hepatic abscess size. In contrast to our initial speculation, mirtazapine may have beneficial effects in sepsis and warrants further exploration.
format Online
Article
Text
id pubmed-7673391
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76733912020-11-26 The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice Davis, Rachelle Paige Almishri, Wagdi Jenne, Craig Neal Swain, Mark Gordon Front Immunol Immunology BACKGROUND AND AIMS: Mirtazapine is an atypical antidepressant with antagonist activity for serotonin and histamine receptors. Clinical and experimental evidence suggests that, in addition to treating depression, mirtazapine also alters liver innate immunity and suppresses immune-driven hepatic macrophage activation. Liver macrophages, Kupffer cells, represent the largest collection of fixed macrophages in the body and are critical in regulating hepatic immunity. In addition to their capacity to regulate inflammation, Kupffer cells are key sentinels for clearing blood-borne pathogens, preventing their dissemination within the body. This process involves pathogen capture, phagocytosis, and activation-induced killing via reactive oxygen species (ROS) production. Therefore, we speculated that mirtazapine might adversely alter Kupffer cell pathogen-associated activation and killing. METHODS: Mice were treated with mirtazapine and time-dependent changes in Kupffer cells were characterized using intravital microscopy. Macrophage and neutrophil responses, bacterial dissemination, and liver damage were assessed following i.v. infection with a pathogenic strain of S. aureus. RESULTS: Mirtazapine rapidly (within 1.5 h) activates Kupffer cells, indicated by a loss of elongated shape with cellular rounding. However, this shape change did not result in impaired pathogen capture function, and, in fact, generated enhanced ROS production in response to S. aureus-induced sepsis. Neutrophil dynamics were altered with reduced cellular recruitment to the liver following infection. Bacterial dissemination post-intravenous administration was not altered by mirtazapine treatment; however, hepatic abscess formation was significantly reduced. CONCLUSIONS: Mirtazapine rapidly activates Kupffer cells, associated with preserved bacterial capture functions and enhanced ROS generation capacity. Moreover, these changes in Kupffer cells were linked to a beneficial reduction in hepatic abscess size. In contrast to our initial speculation, mirtazapine may have beneficial effects in sepsis and warrants further exploration. Frontiers Media S.A. 2020-11-03 /pmc/articles/PMC7673391/ /pubmed/33250892 http://dx.doi.org/10.3389/fimmu.2020.578654 Text en Copyright © 2020 Davis, Almishri, Jenne and Swain http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Davis, Rachelle Paige
Almishri, Wagdi
Jenne, Craig Neal
Swain, Mark Gordon
The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice
title The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice
title_full The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice
title_fullStr The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice
title_full_unstemmed The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice
title_short The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice
title_sort antidepressant mirtazapine activates hepatic macrophages, facilitating pathogen clearance while limiting tissue damage in mice
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673391/
https://www.ncbi.nlm.nih.gov/pubmed/33250892
http://dx.doi.org/10.3389/fimmu.2020.578654
work_keys_str_mv AT davisrachellepaige theantidepressantmirtazapineactivateshepaticmacrophagesfacilitatingpathogenclearancewhilelimitingtissuedamageinmice
AT almishriwagdi theantidepressantmirtazapineactivateshepaticmacrophagesfacilitatingpathogenclearancewhilelimitingtissuedamageinmice
AT jennecraigneal theantidepressantmirtazapineactivateshepaticmacrophagesfacilitatingpathogenclearancewhilelimitingtissuedamageinmice
AT swainmarkgordon theantidepressantmirtazapineactivateshepaticmacrophagesfacilitatingpathogenclearancewhilelimitingtissuedamageinmice
AT davisrachellepaige antidepressantmirtazapineactivateshepaticmacrophagesfacilitatingpathogenclearancewhilelimitingtissuedamageinmice
AT almishriwagdi antidepressantmirtazapineactivateshepaticmacrophagesfacilitatingpathogenclearancewhilelimitingtissuedamageinmice
AT jennecraigneal antidepressantmirtazapineactivateshepaticmacrophagesfacilitatingpathogenclearancewhilelimitingtissuedamageinmice
AT swainmarkgordon antidepressantmirtazapineactivateshepaticmacrophagesfacilitatingpathogenclearancewhilelimitingtissuedamageinmice